Clinical Trials Update: July 9, 2007

Migraine and Cluster Headaches Bipolar Disorders Renal Cell Cancer

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Migraine and Cluster Headaches

This study will evaluate an investigational medication to treat migraines. Volunteers 18-65 who have had migraines for at least 12 months may be included. The study will include seven clinic visits over one year.

The research site is in Mount Pleasant, S.C.

More information

Please see http://www.centerwatch.com/patient/studies/cat100.html.

-----

Bipolar Disorders

This study will evaluate the safety and effectiveness of a medication to treat bipolar disorder. Volunteers 18-65 who do not have HIV infection, and are not pregnant, breastfeeding, or intend to become pregnant during the study may qualify. Women must be at least two years post-menopausal, surgically sterile, or be practicing a medically acceptable method of contraception.

The research site is in Mount Pleasant, Ohio.

More information

Please see http://www.centerwatch.com/patient/studies/cat20.html.

-----

Renal Cell Cancer

Volunteers with advanced renal cell (kidney) cancer that cannot be treated by removing the kidney are invited to participate in this study, which will evaluate different doses and schedules of the study drug, sunitinib malate.

The research site is in Duarte, Calif.

More information

Please see http://www.centerwatch.com/patient/studies/cat680.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News